AlphaFold 3 Advances Immune Research: TGen Scientists Predict T Cell Recognition from Sequence Alone

Scientists at the Translational Genomics Research Institute (TGen), part of City of Hope, have harnessed the AI platform AlphaFold 3 to predict whether a T cell receptor will recognize a specific antigen using only its genetic sequence. This breakthrough could dramatically speed up the study of immune responses to infectious diseases, cancer, and other health threats. By eliminating the need for costly and time-consuming laboratory experiments, researchers can now screen vast numbers of T cell receptors computationally. The method leverages AlphaFold 3's ability to model protein interactions, offering a new window into the immune system's complex recognition process. The team's work, published in a peer-reviewed journal, demonstrates high accuracy in predicting binding between T cell receptors and antigens. This could accelerate the development of personalized immunotherapies and vaccines by identifying which T cells are most likely to respond to a given pathogen or tumor. The approach marks a significant step forward in computational immunology, bridging the gap between sequence data and functional understanding.